Zobrazeno 1 - 10
of 59
pro vyhledávání: '"D M Jensen"'
Autor:
B Nulsen, D M Jensen
Publikováno v:
Digestive diseases and sciences, vol 67, iss 5
B. Nulsen D. M. Jensen.
Parallel independent component analysis (pICA) is a data-driven method that identifies the maximally independent components of multiple imaging modalities while simultaneously investigating the strength of their correlations. Researchers using pICA a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::825ea2c1508313b0b959b68206058893
https://doi.org/10.1101/2020.08.31.276196
https://doi.org/10.1101/2020.08.31.276196
Autor:
B, Nulsen, D M, Jensen, T O G, Kovacs, K A, Ghassemi, M, Kaneshiro, G S, Dulai, R, Jutabha, J A, Gornbein
Publikováno v:
Digestive diseases and sciences. 66(10)
Dieulafoy's lesion (DL) is a rare but increasingly recognized cause of severe upper GI hemorrhage (SUGIH). There is little consensus regarding the endoscopic approach to management of bleeding from DL.Our purposes were to compare 30-day outcomes of p
Autor:
S J, Cotler, R, Patil, R A, McNutt, T, Speroff, G, Banaad-Omiotek, D R, Ganger, H, Rosenblate, S, Kaur, S, Cotler, D M, Jensen
Publikováno v:
The American Journal of Gastroenterology. 96:2730-2736
Hepatitis C is the leading cause of chronic hepatitis in the United States. Little information is available regarding how persons with hepatitis C view health with their disease. We studied patients' perceptions about the value of hepatitis C health
Autor:
I M, Gralnek, R D, Hays, A, Kilbourne, H R, Rosen, E B, Keeffe, L, Artinian, S, Kim, D, Lazarovici, D M, Jensen, R W, Busuttil, P, Martin
Publikováno v:
American Journal of Gastroenterology. 95:3552-3565
Assessment of health-related quality of life (HRQOL) outcomes in studies of liver disease and liver transplantation is necessary. Reliable and valid disease-targeted HRQOL measures are thus needed. The objective of this study was to develop a reliabl
Autor:
Glenn W.W. Gross, Peter B. Cotton, C. Sugawa, Gregory A. Boyce, M. Ament, S. Goodman, John Baillie, P. Petersen, W. C L Wu, J. L. Achord, Francisco C. Ramirez, Frank G. Gress, H. W. Parker, N. A. Jacobson, H W Jr Boyce, J. A. Vennes, R. A. Sanowski, S. P. Martin, Eugene M. Bozymski, R. L. Gebhard, D. M. Jensen, W. J. Ravich
Publikováno v:
Gastrointestinal Endoscopy. 49:845-853
1997-1998 James L. Achord, M.D., Chairman H. Worth Boyce, M.D. Steve Goodman, M.D. Frank Gress, M.D. Glenn W. W. Gross, M.D. Neil A. Jacobson, M.D. Stephen P. Martin, M.D. Paul Petersen, M.D. (TRAINEE) Francisco C. Ramirez, M.D. Choichi Sugawa, M.D.
Autor:
D. M. Jensen, Jose Sanchez, J. Carrier, H. B. De Sant'ana, C. Batut, Philippe Ungerer, Gerard Moracchini
Publikováno v:
Scopus-Elsevier
Revue de l'Institut Français du Pétrole
Revue de l'Institut Français du Pétrole, EDP Sciences, 1998, 53 (3), pp.265-281. ⟨10.2516/ogst:1998024⟩
Revue de l'Institut Français du Pétrole
Revue de l'Institut Français du Pétrole, EDP Sciences, 1998, 53 (3), pp.265-281. ⟨10.2516/ogst:1998024⟩
International audience; Discoveries of oil and gas fields under severe conditions of temperature (above 150°C) or pressure (in excess of 50 MPa) have been made in various regions of the world. In the North Sea, production is scheduled from deep rese
Autor:
L M Blatt, M Klein, Myron J. Tong, F B Hollinger, M Black, H White, R T Foust, J Lubina, D M Jensen, William M. Lee, H Fromm, E J Hathcote, E B Keeffe, E L Krawitt, K R Reddy, P J Pockros, J C Hoefs
Publikováno v:
Hepatology. 26:747-754
This multicenter, randomized, controlled, double-blind, phase III study in 704 patients with chronic hepatitis C infection compared treatment with consensus interferon (CIFN), a non-natural recombinant type-1 interferon, with a standard regimen of re
Autor:
I M, Jacobson, J-M, Pawlotsky, N H, Afdhal, G M, Dusheiko, X, Forns, D M, Jensen, F, Poordad, J, Schulz
Publikováno v:
Journal of viral hepatitis. 19
The aim of this study is to review clinical trial data on the newly approved protease inhibitors boceprevir and telaprevir to develop consensus recommendations on the optimal use of these agents for the treatment of patients with chronic hepatitis C